Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Immunol Res. 2011 Dec;51(2-3):237-48. doi: 10.1007/s12026-011-8257-3.
CD4+ T cells (T(CD4+)) are activated by peptides, generally 13-17 amino acids in length, presented at the cell surface in combination with highly polymorphic MHC class II molecules. According to the classical model, these peptides are generated by endosomal digestion of internalized antigen and loaded onto MHC class II molecules in the late endosome. Historically, this "exogenous" pathway has been defined through the extensive use of purified proteins. However, the relatively recent use of clinically relevant antigens, those of influenza virus in our case, has revealed several additional pathways of peptide production, including some that are truly "endogenous", entailing synthesis of the protein within the infected cell. Indeed, some peptides appear to be created only via endogenous processing. The cell biology that underlies these alternative pathways remains poorly understood as do their relative contributions to defence against infectious agents and cancer, and the triggering of autoimmune diseases.
CD4+ T 细胞(T(CD4+))被肽激活,这些肽通常长度为 13-17 个氨基酸,与高度多态性 MHC Ⅱ类分子一起在细胞表面呈现。根据经典模型,这些肽是通过内吞作用内化的抗原在内体中的消化产生的,并加载到晚期内体中的 MHC Ⅱ类分子上。从历史上看,通过广泛使用纯化蛋白来定义这条“外源性”途径。然而,最近使用临床相关抗原,例如我们案例中的流感病毒抗原,揭示了几种其他肽产生途径,包括一些真正的“内源性”途径,涉及受感染细胞内蛋白质的合成。事实上,一些肽似乎仅通过内源性加工产生。这些替代途径所依据的细胞生物学仍然知之甚少,它们对防御感染因子和癌症以及引发自身免疫性疾病的相对贡献也知之甚少。